Browsing: PB223

Research

Precision Biologics’ New PB-223 ADC Targeting Multiple Cancer Types to Be Highlighted in Keynote at 6th ACE Drug Discovery Summit

By NewsCancerFebruary 16, 20260

London, UK – February 19, 2026BETHESDA, Md., Feb. 13, 2026 /PRNewswire/ – Precision Biologics, Inc. CEO Philip M. Arlen, MD gives a Keynote…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.